Verdant PhytoMed — Products & Services
Verdant PhytoMed’s product portfolio has been designed to address the full spectrum of pharmaceutical-grade medicinal cannabis demand across international markets. All products are manufactured in compliance with EU-GMP standards and undergo rigorous quality testing including High Performance Liquid Chromatography (HPLC), microbial screening,…
Section 4 · Business Plan
Products & Services
Verdant PhytoMed’s product portfolio has been designed to address the full spectrum of pharmaceutical-grade medicinal cannabis demand across international markets. All products are manufactured in compliance with EU-GMP standards and undergo rigorous quality testing including High Performance Liquid Chromatography (HPLC), microbial screening,…
4.1 Product Portfolio
Verdant PhytoMed’s product portfolio has been designed to address the full spectrum of pharmaceutical-grade medicinal cannabis demand across international markets. All products are manufactured in compliance with EU-GMP standards and undergo rigorous quality testing including High Performance Liquid Chromatography (HPLC), microbial screening, heavy metal analysis, pesticide residue testing, and terpene profiling.
Product Line 1: Dried Medicinal Cannabis Flower (EU-GMP Grade)
Pharmaceutical-grade dried cannabis flower, cultivated under GACP conditions and processed in GMP-certified facilities. Available in standardised THC-dominant, CBD-dominant, and balanced chemotype strains. Target markets include German pharmacies (Apotheken), UK specialist clinics, and Australian Therapeutic Goods Administration (TGA)-approved distributors.
Cape Town), depending on cannabinoid profile and strain
total revenue
Product Line 2: Cannabis Extracts & Oils
Full-spectrum and broad-spectrum cannabis extracts, CBD isolate, and standardised oil formulations. These products target pharmaceutical manufacturers, compounding pharmacies, and nutraceutical companies seeking bulk active pharmaceutical ingredients (APIs).
extract (concentration-dependent)
total revenue
Product Line 3: Pharmaceutical Bulk Inputs & Research Supply
Bulk cannabis biomass and standardised cannabinoid reference materials supplied to pharmaceutical R&D departments, university research programmes, and contract research organisations (CROs). This revenue stream builds long-term strategic relationships and positions the Company as a preferred supplier in the scientific community.
total revenue
4.2 Quality Assurance Framework
The Company’s quality management system (“QMS”) is designed to meet or exceed the following international standards:
-
EU-GMP (European Medicines Agency guidelines for medicinal cannabis)
-
GACP (WHO Good Agricultural and Collection Practices)
-
ISO 17025 (laboratory testing and calibration)
-
HACCP (Hazard Analysis and Critical Control Points for food-grade processing)
-
Full seed-to-sale traceability via integrated ERP and track-and-trace software
This document contains proprietary and confidential information. Distribution without written consent is prohibited.